NUP98-rearranged acute myeloid leukemia expresses high levels of CDK6 and is hypersensitive to Palbociclib treatment

被引：0
|
作者：
Schmoellerl, J. [1 ]
Barbosa, I. [2 ]
Van der Veen, C. [1 ]
Eder, T. [1 ]
Schmidt, L. [1 ]
Brandstoetter, T. [3 ]
Maurer, B. [3 ]
Terlecki, S. [1 ]
Hoermann, G. [4 ]
Valent, P. [4 ]
Jude, J. [2 ]
Sexl, V. [3 ]
Zuber, J. [2 ]
Grebien, F. [1 ,5 ]
机构：
[1] Ludwig Boltzmann Inst Canc Res, Vienna, Austria
[2] Res Inst Mol Pathol IMP, Vienna, Austria
[3] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria
[4] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[5] Univ Vet Med, Inst Med Biochem, Vienna, Austria
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V161
引用
收藏
页码：40 / 40
页数：1
相关论文
共 38 条
  • [21] Two Cases of Pediatric Acute Myeloid Leukemia with FLT3-ITD and NUP98-NSD1 Co-Expression that Responded to Gilteritinib Treatment
    Abematsu, Takanari
    Nishikawa, Takuro
    Nakamura, Tatsuro
    Matsuishi, Toshiya
    Nakagawa, Shunsuke
    Kodama, Yuichi
    Okamoto, Yasuhiro
    Kawano, Yoshifumi
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [22] Involvement of the NUP98 gene in a novel t(6;11)(q25;p15) in a patient with myeloid/T acute byphenotypic leukemia.
    Odero, MD
    Lahortiga, I
    Vizmanos, JL
    Vazquez, I
    Perez-Equiza, K
    Gorosquieta, A
    Novo, FJ
    Calasanz, MJ
    BLOOD, 2002, 100 (11) : 192B - 192B
  • [23] Serum hepcidin levels related to interlukin-6 in patients with acute myeloid leukemia before and after treatment
    Ali, Khitam Abdulwahhab
    Mohammad, Hiba Ammar
    Naji, Alaadin Sahham
    Alwan, Alaa Fadhil
    IRAQI JOURNAL OF HEMATOLOGY, 2022, 11 (01) : 76 - 82
  • [24] Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
    Yuichi Mitani
    Mitsuteru Hiwatari
    Masafumi Seki
    Mayumi Hangai
    Junko Takita
    International Journal of Hematology, 2019, 110 : 512 - 516
  • [25] Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
    Mitani, Yuichi
    Hiwatari, Mitsuteru
    Seki, Masafumi
    Hangai, Mayumi
    Takita, Junko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (04) : 512 - 516
  • [26] Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6; II )(q24. I ;p I 5.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia
    Tosi, S
    Ballabio, E
    Teigler-Schlegel, A
    Boultwood, J
    Bruch, J
    Harbott, J
    GENES CHROMOSOMES & CANCER, 2005, 44 (03): : 225 - 232
  • [27] Recurrent Genomic Aberrations of D-Type Cyclins Are Therapeutic Targets of CDK4/6 Inhibitors in t(8;21) and MLL-Rearranged Acute Myeloid Leukemia
    Matsuo, Hidemasa
    Yoshida, Kenichi
    Fukumura, Kazutaka
    Nakatani, Kana
    Noguchi, Yuki
    Takasaki, Saho
    Noura, Mina
    Shiozawa, Yusuke
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Okada, Ai
    Nannya, Yasuhito
    Takeda, June
    Ueno, Hiroo
    Shiba, Norio
    Yamato, Genki
    Kiyokawa, Nobutaka
    Tomizawa, Daisuke
    Taga, Takashi
    Tawa, Akio
    Hayashi, Yasuhide
    Mano, Hiroyuki
    Miyano, Satoru
    Kamikubo, Yasuhiko
    Ogawa, Seishi
    Adachi, Souichi
    BLOOD, 2018, 132
  • [28] Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia: A pediatric case report
    Wen, Xiaojia
    Wu, Ying
    Huang, Pengli
    Zheng, Huyong
    PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
  • [29] ETH-155008, a Novel Selective Dual Inhibitor of FLT3 and CDK4/6 in Preclinical Treatment of Acute Myeloid Leukemia
    Liu, Changnian
    Liu, Bin
    Xu, Chunping
    Zhang, Pan
    Li, Bin
    Ji, Bin
    Zhang, Bin
    Liu, Qingjun
    Zhang, James
    Yu, Chengzhi
    BLOOD, 2019, 134
  • [30] Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT
    Sun, Haimin
    Yan, Han
    Yan, Zeying
    Zhu, Yongmei
    Yang, Guang
    Zhang, Sujiang
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 473 - 475
1234